Can a patient be both normosthenic and obese?

Can a Patient Be Both Normosthenic and Obese?

Yes, a patient can absolutely be both normosthenic (normal body weight by BMI) and obese (excess body fat), a condition formally recognized as "normal-weight obesity." This represents a critical diagnostic pitfall where reliance on BMI alone fails to identify individuals with excess adiposity and significant cardiometabolic risk.

Understanding Normal-Weight Obesity

The term "normosthenic" traditionally refers to normal body build or weight, typically assessed by BMI. However, BMI has poor sensitivity (only 36% in men and 49% in women) for detecting true obesity defined by body fat percentage 1. This means that approximately half of individuals with excess body fat are missed when using BMI alone 1.

Defining the Condition

Normal-weight obesity occurs when individuals have:

• BMI in the normal range (18.5-24.9 kg/m²) 2
• Elevated body fat percentage (≥25% in men, ≥35% in women) 1
• Increased cardiometabolic risk despite "normal" weight 1

This phenomenon is also called "metabolically obese, normal-weight" (MONW) individuals 3, 4.

Clinical Significance and Risk Profile

Patients with normal-weight obesity face substantially elevated health risks:

• 7-fold increased risk of metabolic syndrome in women (4-fold in men) with high body fat percentage despite normal BMI 1
• Nearly 2-fold increased mortality risk in women with normal-weight obesity compared to those with lower body fat 1
• Higher prevalence of dyslipidemia, type 2 diabetes, hypertension, and cardiovascular disease 1, 5
• Increased risk even when central obesity measures (waist circumference) appear normal 1

The research demonstrates that these individuals are hyperinsulinemic, insulin-resistant, and predisposed to premature coronary heart disease 3.

Why BMI Fails in These Patients

BMI cannot distinguish between lean mass and fat mass 1. The calculation uses total body weight without accounting for body composition, leading to:

• Individuals with normal weight but excess body fat going undiagnosed
• Misclassification based on age, sex, and ethnicity differences in body composition 1
• At similar BMI levels, women have higher body fat percentages than men 1
• Ethnic variations exist (Hispanic women have higher body fat than Black and White women at the same BMI) 1

Practical Clinical Approach

To identify normal-weight obesity, clinicians must look beyond BMI:

Assessment Strategy

1. Measure body composition using validated techniques:

   • Bioelectrical impedance analysis (BIA)
   • Dual-energy X-ray absorptiometry (DXA) - most accurate 2
   • Body fat percentage thresholds: ≥25% (men), ≥35% (women) 1

2. Assess fat distribution patterns:

   • Waist circumference (≥102 cm men, ≥88 cm women indicates central obesity) 6
   • Waist-to-hip ratio
   • Note: Some normal-weight obese individuals may have normal waist circumference yet still carry excess visceral fat 1

3. Screen for metabolic complications:

   • Fasting glucose and insulin levels
   • Lipid panel (triglycerides, HDL cholesterol)
   • Blood pressure
   • Markers of insulin resistance

4. Evaluate functional capacity:

   • Physical activity level
   • VO2max or exercise tolerance
   • Muscle strength assessment

Key Clinical Pitfalls

The most dangerous error is assuming normal BMI equals metabolic health. This false reassurance leads to:

• Missed opportunities for early intervention 4
• Progression to overt type 2 diabetes and cardiovascular disease
• Development of irreversible complications (nephropathy, ischemic heart disease) that may be present at diagnosis 3

Common scenarios where normal-weight obesity occurs:

• Sedentary individuals with low muscle mass but increased fat mass
• Those with central/visceral fat accumulation despite normal total weight
• Patients who have lost muscle mass due to aging or inactivity while maintaining stable weight
• Individuals with modest weight gain (2-10 kg) in adult life despite remaining in "normal" BMI range 3

Management Implications

These patients require the same aggressive lifestyle interventions as overtly obese individuals 3, 4:

• Structured exercise programs emphasizing both aerobic and resistance training
• Dietary modification to reduce adiposity while preserving lean mass
• Targeting insulin resistance and metabolic abnormalities
• Potentially pharmacological intervention for metabolic syndrome components

The advantage of early identification is that these patients are typically younger and more responsive to diet and exercise therapy than those with established obesity and disease 3.

Bottom Line

The concept of "normosthenic" based solely on BMI is outdated and clinically inadequate. A patient with normal BMI can absolutely have obesity when properly assessed by body composition, and these individuals face significant cardiometabolic risks that demand recognition and treatment 1, 5, 3. Clinicians must incorporate body composition assessment and metabolic screening beyond simple weight and height measurements to avoid missing this high-risk population.